SCOPUS 정보 검색 플랫폼

Southern Medical Journal

Volumn 94, Issue 3, 2001, Pages 353-355

Vancomycin-Resistant Enterococcus faecium Osteomyelitis: Successful Treatment with Quinupristin-Dalfopristin

(3) Summers, Mark a Misenhimer, Gregory R a Antony, Suresh J a

a El Paso Cancer Treatment Center (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN-DALFOPRISTIN; VIRGINIAMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CASE REPORT; DRUG EFFECT; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; OSTEOMYELITIS;

AGED; ANTI-BACTERIAL AGENTS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; OSTEOMYELITIS; VANCOMYCIN RESISTANCE; VIRGINIAMYCIN;

EID: 0035290924 PISSN: 00384348 EISSN: None Source Type: Journal
DOI: 10.1097/00007611-200194030-00018 Document Type: Article

Times cited : (21)

References (16)

1
- 0029979355
- Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against Enterococcus species
- Cormican MG, Johnson DM, Jones RN: Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against Enterococcus species. Diagn Microbiol Infect Dis 1996; 24:59-60
- (1996) Diagn Microbiol Infect Dis , vol.24 , pp. 59-60
- Cormican, M.G.¹ Johnson, D.M.² Jones, R.N.³

2
- 0027910517
- Nosocomial enterococci resistant to vancomycin - US, 1989-1993
- Nosocomial enterococci resistant to vancomycin - US, 1989-1993. MMWR Morb Mortal Wkly Rep 1993; 42:597-599
- (1993) MMWR Morb Mortal Wkly Rep , vol.42 , pp. 597-599

3
- 0002466577
- Enterococci
- Gorbach SL, Bartlett JG, Blacklow NR (eds). Philadelphia, WB Saunders Co
- Murray BE: Enterococci. Infectious Diseases. Gorbach SL, Bartlett JG, Blacklow NR (eds). Philadelphia, WB Saunders Co, 1992, pp 1415-1420
- (1992) Infectious Diseases , pp. 1415-1420
- Murray, B.E.¹

4
- 0026645135
- Emergence of enterococcus as a significant pathogen
- Moellering RC Jr: Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992; 14:1173-1178
- (1992) Clin Infect Dis , vol.14 , pp. 1173-1178
- Moellering R.C., Jr.¹

5
- 0029761049
- Vancomycin-resistant Enterococcus faecium in the IGU and quinupristin-dalfopristin
- Zervos M: Vancomycin-resistant Enterococcus faecium in the IGU and quinupristin-dalfopristin. New Horizon 1996; 4:385-392
- (1996) New Horizon , vol.4 , pp. 385-392
- Zervos, M.¹

6
- 0030058705
- Wound management in spinal infection
- Rubayi S: Wound management in spinal infection. Orthop Clin North Am 1996; 27:137-153
- (1996) Orthop Clin North Am , vol.27 , pp. 137-153
- Rubayi, S.¹

7
- 0030033485
- Cervical spine infections
- Ghanayem AJ, Zoleblick TA: Cervical spine infections. Orthop Clin North Am 1996; 27:53-67
- (1996) Orthop Clin North Am , vol.27 , pp. 53-67
- Ghanayem, A.J.¹ Zoleblick, T.A.²

8
- 0347542951
- Resistant nosocomial enterococcal infection
- Schaberg DR: Resistant nosocomial enterococcal infection. Infect Dis Newsletter 1988; 7:73-75
- (1988) Infect Dis Newsletter , vol.7 , pp. 73-75
- Schaberg, D.R.¹

9
- 0024585349
- Enterococcal bacteremia: Analysis of 75 episodes
- Gullberg RM, Homann SR, Phair JP: Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989; 11:74-85
- (1989) Rev Infect Dis , vol.11 , pp. 74-85
- Gullberg, R.M.¹ Homann, S.R.² Phair, J.P.³

10
- 0025881126
- Enterococcal bacteremia: To treat or not to treat, a reappraisal
- Hoge CW, Adams J, Buchanan B, et al: Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991; 12:600-605
- (1991) Rev Infect Dis , vol.12 , pp. 600-605
- Hoge, C.W.¹ Adams, J.² Buchanan, B.³

11
- 0028887658
- Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome
- Noskin GA, Peterson LR, Warren JR: Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995; 20:296-301
- (1995) Clin Infect Dis , vol.20 , pp. 296-301
- Noskin, G.A.¹ Peterson, L.R.² Warren, J.R.³

12
- 0030928298
- Activity of quinupristin/dalfopristin against gram-positive bacteria: Clinical applications and therapeutic potential
- Rubenstein E, Bompart F: Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential. J Antimicrob Chemother 1997; 39:139-143
- (1997) J Antimicrob Chemother , vol.39 , pp. 139-143
- Rubenstein, E.¹ Bompart, F.²

13
- 0031010340
- In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin
- Bouanchaud DH: In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin. J Antimicrob Chemother 1997; 39:15-21
- (1997) J Antimicrob Chemother , vol.39 , pp. 15-21
- Bouanchaud, D.H.¹

14
- 10544233012
- Treatment of vancomycin-resistant Enterococcus faecium infections
- Lai KK: Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Intern Med 1996; 156:2579-2584
- (1996) Arch Intern Med , vol.156 , pp. 2579-2584
- Lai, K.K.¹

15
- 0030040382
- Wound infections in reconstructive spine surgery
- Theiss S, Lonstein J, Winter RB: Wound infections in reconstructive spine surgery. Orthop Clin North Am 1996; 27:105-110
- (1996) Orthop Clin North Am , vol.27 , pp. 105-110
- Theiss, S.¹ Lonstein, J.² Winter, R.B.³

16
- 0029361847
- Quinupristin/dalfopristin: Spectrum of activity pharmacokinetics and initial clinical experience
- Low DE: Quinupristin/dalfopristin: spectrum of activity pharmacokinetics and initial clinical experience. Microb Drug Resist 1995; 3:223-234
- (1995) Microb Drug Resist , vol.3 , pp. 223-234
- Low, D.E.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.